INSAF

PHARMACEUTICAL
To be the most admired healthcare company in kohat
 01 INSAF Emeprazole Capsule

Products 02 INSAF Emeprazole sachet

Vision:
To Provide medicines which meet their quality
Standards with low cost.

Mission:
Insaf Pharmaceutical believes to provide, Service to all sector
society by following ethics properly, and without Compromising
quality.
Marketing:
Market Research AND Analysis:
We decide to launch only two products named
 INSAF Emeprazole Capsule
 INSAF Emeprazole sachet

We have Research in a Market that Doctor prefer to a Quality

product .
And we analyzed that demand for these two product are pretty
well.
Target market identified:
Our Target Market comprises:
 Doctors
 Pharmacies

Market Segmentation :
We have Identified our Market Size at Kohat , Hangu, Tal,
Dawaba, Sadda and Parachinar.
And among these our best market size are Kohat and
Parachinar.
Competitor Analysis :

By Successfully Competitor analysis in a market that

these products are available in a market with many
Companies. Many of them Provide good quality but
with high prices.

So we decide to introduce our products in a market with

best Quality and low price as compare to others.
Price Strategy:

We decide that our product should be less than others. According to

marketing research other companies price of
INSAF Emeprazole Capsule = Rs 320 to 350 and
INSAF Emeprazole sachet = Rs 220 to 250.
So we decide our product price will be
INSAF Emeprazole Capsule = Rs 295 and
INSAF Emeprazole sachet = Rs 195
Swot analysis:
Strengt Weakness Opportunit Threats
h es ies
Quality Safety of Global Constant
Products Drugs Demand for increasing
Affects products inflation
Low Alternative Positive
Price Products Approach of Manufacturin
Doctors g Issues
4ps :

Product:
We provide Cranberry Sache which are helpful in UTI
preventions and
Iron Syrup helps and treat iron deficiency anemia
treatment.

Price:
We provide High Quality product and Low Price.
Place :

Our Products will be available at Kohat , Hangu, Tal,

Sadda , Dawaba, and Parachinar.

Promotion:

We usually promote our product with Face to Face

meeting with Doctors and Pharmacies.
Financial plan:
We want to finance growth through a sweat equity of
the founders. Since we have Invested Rs 1,50,000 as a
startup Funding.
(1)Contact With EON Pharmaceutical
Manufacturing Company Karachi
Product Costing :

INSAF Emeprazole Capsule MRP (Rs 295)

INSAF Emeprazole sachet. MRP (Rs 195)

EON Will provide 70% Discount so

295-70%= Per Pack Rs 88.5
195-70%= Per Pack Rs 58.5
Purchasing Cost:
Cranberry: 88.5*1000= Rs 88500
Iron = 58.5*1000= Rs 58500
Total Order Cost= Rs 147000

Transportation Cost:
Cost Per cotton=Rs 100
One cotton contains 100 Packs, then
20 Cotton*100= Rs 2000
Distribution Cost:
They Decide to take 10% charges,
INSAF Emeprazole Capsule MRP 295*1000= Rs 295000
INSAF Emeprazole sachet MRP 195*1000= Rs 195000
Total Inventory Stock= Rs 4,90,000
Distribution Charges 10% on total Amount
490000*10%= Rs49000
Employees Salary:
20000*2= Rs 40000

Retailer Margin for Pharmacy Shops:

490000*15%= Rs 73500
Doctor Activities:
Doctor Percentage deducted after the remaining
amount to pharmacy shops
So we give 15% to Retail shops
and 25% to doctors
490000-15%= Rs 73500
416500-25%= Rs 104125
Startup :

Start UP Expenses Amount

Salaries Rs 40,000
Transportation Rs 2000
Distribution Rs 49000
Retail Margin Rs 73500
Doctor Activities Rs 104125
TOTAL START UP EXPENSES Rs 268,625
Assets
Start up Inventory Rs 147000
Total Assets Rs 147000

Total Requirements Rs 415,625

 INSAF Pharmaceutical
Income Statement
For the End June 31,2021
Revenue
Rs 4,90,000
Expenses
Salaries Expense Rs 40,000
Transportation Rs 2000
Distribution Rs 49,000
Retail Margin Rs 73500
Doctor Activities Rs 104125

Total Expenses Rs 415,625

Net Income
Rs 74375
 Balance sheet :

INSAF Pharmaceutical
Balance Sheet
At the End of July , 2021
Assets (PKR) Liabilities and owner Equity (PKR)

Current Assets Liabilities Rs 0

Inventories Rs 147,000 Owners Equity

Office Equipment Rs 3000 INSAF Pharmaceutical Equity Rs 1,50,000

Total Assets Rs 1,50,000 Total Liabilities and Equity Rs 1,50,000

Sales forcast:
Serial No Month Unit Sold Price
Product per
Unit(PKR)
Product 1= 295
Product 2= 195
1 January 2000 4,90,000
2 February 2050 502,250
3 March 2100 514,500
4 April 2150 526,750
5 May 2200 539,000
6 June 2250 551,250
7 July 2300 563,500
8 August 2350 575,750
9 September 2400 588,000
10 October 2500 612,500
11 November 2550 624,750
Office forcasting :
Serial No Month Sale Total Profit
Requirements
1 Jan 4,90,000 415,625 74375
2 Feb 502,250 415,650 86600
3 Mar 514,500 415,675 98,825
4 Apr 526,750 415,700 111,050
5 May 539,000 415,725 123,275
6 Jun 551,250 415,750 135,500
7 July 563,500 415,775 147,725
8 Aug 575,750 415,800 159,950
9 Sept 588,000 415,825 172,175
10 Oct 612,500 415,850 196,650
11 Nov 624,750 415,875 208,875
12 Dec 637,000 415,900 221,100
How We measure Our Success:
Since we have no current Liabilities, Account
Receivables , no debt, EBIT, interest Expense, that’s
why the only key indicator of our success are the two
key ratio which are given below.

(1) Total Assets Turnover= Net Sales/Total Assets

Rs 637000 / Rs150000 = 4.24

(2) Inventory Turnover = COGS/ Inventory

Rs 4,90,000/ Rs 147000= 3.33
 20XX

THANK YOU ！
Enter text here

Reporter ： *** Date ： 2019.4